MassMutual Private Wealth & Trust’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.36K Buy
1,176
+176
+18% +$540 ﹤0.01% 1769
2026
Q2
$3.04K Hold
1,000
– – ﹤0.01% 1870
2026
Q1
$3.08K Buy
1,000
+82
+9% +$348 ﹤0.01% 1850
2025
Q4
$3.31K Buy
918
+500
+120% +$2.18K ﹤0.01% 1837
2025
Q3
$1.58K Buy
+418
New +$1.61K ﹤0.01% 2043
2025
Q2
– Sell
-240
Closed -$1.2K – 2352
2025
Q1
$1.2K Buy
240
+78
+48% +$494 ﹤0.01% 2074
2024
Q4
$1.17K Buy
+162
New +$1.24K ﹤0.01% 1985

Other funds holding ALT

MassMutual Private Wealth & Trust's ALT Position: Q3 2026 in Review

MassMutual Private Wealth & Trust increased its Altimmune (ALT) stake by 18% in Q3 2026, buying an estimated $540 and bringing the position to 1,176 shares worth $3.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

MassMutual Private Wealth & Trust first reported a position in ALT in Q4 2024 and has held it in 7 quarters since. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • MassMutual Private Wealth & Trust held 1,176 shares of Altimmune worth $3.36K as of Q3 2026.
  • MassMutual Private Wealth & Trust bought 176 Altimmune shares in Q3 2026, an estimated $540.
  • Altimmune made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1769 holding.
  • MassMutual Private Wealth & Trust first reported a position in Altimmune in Q4 2024 and has held it in 7 quarters since.
  • 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.